Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Xian-Gui Peng"'
Autor:
Fang Liu, Jishi Wang, Jingkang Xiong, Sanbin Wang, Xi Zhang, Cheng Zhang, Pei-Yan Kong, Jun Rao, Qiong Li, Lei Gao, Yao Liu, Li Gao, Xian-Gui Peng, Qin Wen
Publikováno v:
Current Medical Science. 41:465-473
The role of autologous hematopoietic stem cell transplantation (auto-HSCT) following high-dose chemotherapy has been validated and accepted as a standard treatment for patients with relapsed diffuse large B-cell lymphoma (DLBCL). However, its clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70515a60af6072fa3a27c9ed06e2ed80
https://doi.org/10.1007/s11596-021-2394-2
https://doi.org/10.1007/s11596-021-2394-2
Autor:
Jiali Li, Ping Wang, Wei Zhang, Jun Rao, Chao Yang, Pei-Yan Kong, Lidan Zhu, Jingkang Xiong, Xi Zhang, Jiang F. Zhong, Yao Liu, Qiong Li, Deng Xiaojuan, Xian-Gui Peng
Publikováno v:
Cancer Management and Research. 12:11411-11419
Introduction Increasing evidence has demonstrated that plasmacytoid dendritic cells (PDCs) in the tumor microenvironment (TME) play an important role in tumorigenesis and progression. PDC infiltration has been found in certain malignancies such as cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad59f1d5e27fb9613e1a2786443d49a8
https://doi.org/10.2147/cmar.s260825
https://doi.org/10.2147/cmar.s260825
Autor:
Xi Zhang, Pei-Yan Kong, Cheng Zhang, Qiong Li, Wei Zhang, Jiali Li, Jun Rao, Lei Gao, Li Gao, Jingkang Xiong, Yunjing Zeng, Jia Liu, Qin Wen, Xian-Gui Peng, Yao Liu, Ting Chen
Publikováno v:
Biomarker Research, Vol 8, Iss 1, Pp 1-12 (2020)
Background The early detection of tumors upon initial diagnosis or during routine surveillance is important for improving survival outcomes. Here, we investigated the feasibility and clinical significance of circulating tumor DNA (ctDNA) detection fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5552a6b1cfcfa9f5bddaeef5dbb34133
http://link.springer.com/article/10.1186/s40364-020-00205-4
http://link.springer.com/article/10.1186/s40364-020-00205-4
Autor:
Xi Zhang, Pei-Yan Kong, Lei Gao, Shifeng Lou, Maihong Wang, Xixi Xiang, Jiangfan Zhong, Lidan Zhu, Yao Liu, Jiali Li, Cheng Zhang, Xue Liu, Xian-Gui Peng, Tonghua Yang, Sha Zhou, Li Gao, Bin Li, Qin Wen, Sanbin Wang, Jun Rao
Publikováno v:
Haematologica
T-cell lymphoblastic lymphoma (T-LBL) is a highly aggressive form of lymphoma with poor clinical outcomes and no standard treatment regimen. In this study, we assessed the safety and efficacy of tandem autologous hematopoietic stem cell transplantati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6b6fc18a2b714a7f109f11c1cd5650f
http://europepmc.org/articles/PMC7776263
http://europepmc.org/articles/PMC7776263
Autor:
Sanbin Wang, Tao Lang, Jishi Wang, Lidan Zhu, Jiang F. Zhong, Cunbang Wang, Xi Zhang, Jiong Hu, Cheng Zhang, Yi Su, Tonghua Yang, Xian-Gui Peng, Yanqi Zhang, Hai Bai, Yao Liu, Le Luo, Ting Chen, Pei-Yan Kong, Min Mao, Qin Wen, Lei Gao, Jun Rao, Kaniel Cassady, Hong Liu, Shifeng Lou, Jia Liu, Fang Liu, Ming Jiang, Li Gao, Ping Wang, Xianlin Duan, Xiaobing Huang, Li Liu
Publikováno v:
Journal of Clinical Oncology
PURPOSE Relapse is a major cause of treatment failure after allogeneic hematopoietic stem-cell transplantation (allo-HSCT) for high-risk acute myeloid leukemia (HR-AML). The aim of this study was to explore the effect of recombinant human granulocyte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab22c8b19b3e724e32b5a2dc93f32b66
https://pubmed.ncbi.nlm.nih.gov/33108244
https://pubmed.ncbi.nlm.nih.gov/33108244
Autor:
Xi Zhang, Qin Wen, Pei-Yan Kong, Cheng Zhang, Xian-Gui Peng, Yao Liu, Jiali Li, Xixi Xiang, Li Gao, Di Yuan, Lei Gao
Publikováno v:
Acta Biochimica et Biophysica Sinica. 50:800-806
T-cell lymphomas (TCLs) are a malignancy characterized by tumor aggression and resistance to traditional chemotherapy. Disruption of the extrinsic cell death pathway is essential for resistance to chemotherapy. PIM1 serves as a crucial modulator in c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f36e6877ebeb8e10e1acc74269a8a5f
https://doi.org/10.1093/abbs/gmy076
https://doi.org/10.1093/abbs/gmy076
Autor:
Cheng Zhang, Xian-Gui Peng, Ying-Ying Ma, Xi Zhang, Li Gao, Jun Liu, Lei Gao, Xu Tan, P Y Kong, Yao Liu
Publikováno v:
Clinical lymphoma, myelomaleukemia. 19(7)
Background Approximately 30% to 60% of patients with acute B-lymphocytic leukemia (B-ALL) show as refractory or relapsed, which is one of the major causes of death in patients with B-ALL, but the methods of the treatment for relapsed/refractory B-ALL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c735bd207232318098dca8d0950ca26
https://pubmed.ncbi.nlm.nih.gov/31076372
https://pubmed.ncbi.nlm.nih.gov/31076372
Autor:
Xianlin Duan, Qin Wen, Jun Rao, Xi Zhang, Yao Liu, Ming Jiang, Hai Bai, Min Mao, Jishi Wang, Yi Su, Lidan Zhu, Xiao-Bin Huang, Peiyan Kong, Li Liu, Sanbin Wang, Ping Wang, Jiong Hu, Tao Lang, Shifeng Lou, Jiangfan Zhong, Cunbang Wang, Le Luo, Ting Chen, Fang Liu, Lei Gao, Kaniel Cassady, Li Gao, Xian-Gui Peng, Cheng Zhang, Tonghua Yang, Yanqi Zhang, Hong Liu, Jia Liu
Publikováno v:
SSRN Electronic Journal.
Background: Recurrence is a major cause of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for high-risk acute myeloid leukemia (HR-AML). Recent studies have indicated that granulocyte colony-stimulating factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb86f927a510684b5c08644c3c9a6d9a
https://doi.org/10.2139/ssrn.3487826
https://doi.org/10.2139/ssrn.3487826
Autor:
Sha Zhou, Xian-Gui Peng, Xixi Xiang, Cheng Zhang, Maihong Wang, Lidan Zhu, Shifeng Lou, Lei Gao, Sanbin Wang, Jiangfan Zhong, Xue Liu, Jun Rao, Jiali Li, Xi Zhang, Li Gao, Yao Liu, Bin Li, Tonghua Yang, Peiyan Kong, Qin Wen
Publikováno v:
SSRN Electronic Journal.
Background: T-cell lymphoblastic lymphoma (T-LBL) is a highly aggressive form of lymphoma with poor clinical outcomes and lack of a standard treatment regimen. Accordingly, this study evaluated the safety and efficacy of tandem autologous hematopoiet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e67ffdb7d9bc2642c1334ebf86f2a5e
https://doi.org/10.2139/ssrn.3315844
https://doi.org/10.2139/ssrn.3315844
Autor:
Zhi Yang, Meiling Wang, Shiqi Li, Ai-Hua Sun, Peiyan Kong, Xun Ni, Lei Gao, Ting Chen, Gao Li, Xi Zhang, Yao Liu, Xian-Gui Peng, Cheng Qian, Cheng Zhang, Yunyan Li, Ping Wang
Publikováno v:
Journal of immunotherapy (Hagerstown, Md. : 1997). 41(6)
Background Reduced-intensity conditioning (RIC) regimens with low tolerable toxicities have been used for allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the relapse rate by this treatment is high. Treatment of CD19 B-cell re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f141375e82190153efed248595e970c8
https://pubmed.ncbi.nlm.nih.gov/29864079
https://pubmed.ncbi.nlm.nih.gov/29864079